BIOLOGY OF REPRODUCTION, BIOL REPROD. 2006 May;74(5):954-8. Mechanism of action of L-arginine on the vitality of spermatozoa is primarily through increased biosynthesis of nitric oxide.

Davies MG, Fulton GJ & Hagen PO (1995). Clinical biology of nitric oxide. British Journal of Surgery, 82: 1598-1610.

Zini A, O'Bryan MK & Schlegel PN (2001). Nitric oxide synthase activity in human seminal plasma. Urology, 58: 85-89.

Sharma RK, Pasqualotto FF, Nelson DR et al. (1999). The reactive oxygen species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Human Reproduction, 14: 2801-2807.

The ESHRE Capri Workshop Group (1996). Infertility revisited: the state of the art today and tomorrow. Human Reproduction, 11: 1779-1807.

Harrison RF, O'Moore RR & O'Moore AM (1986). Stress and fertility: some modalities of investigation and treatment in couples with unexplained infertility in Dublin. International Journal of Fertility, 31: 153-159.

Effects of ferulic acid on fertile and asthenozoospermic infertile human sperm motility, viability, lipid peroxidation, and cyclic nucleotides; Free Radic Biol Med. 1997;22(4):581-6

Hjollund NH, Jensen TK, Bonde JP et al. (1999). Distress and reduced fertility: a follow-up study of first-pregnancy planners. Fertility and Sterility, 72: 47-53.

Harlow CR, Fahy UM, Talbot WM et al. (1996). Stress and stress-related hormones during in vitro fertilization treatment. Human Reproduction, 11: 274-279.

Boivin J, Shoog-Svanberg A, Andersson L et al. (1998). Distress level in men undergoing intracytoplasmic sperm injection versus in vitro fertilization. Human Reproduction, 13: 1403-1406.

Hallemeesch MM, Lamers WH & Deutz NE (2002). Reduced arginine availability and nitric oxide production. Clinical Nutrition, 21: 273-279.

Turek P (2000). Male infertility. In: Tanagho EM & McAninch JW (Editors), Smith's General Urology. McGraw-Hill Co., New York.

World Health Organization (1993). WHO Laboratory Manual for the Examination of Human Sperm and Semen Cervical Mucus Interaction. Cambridge University Press, New York.

Geyer JW & Dabich D (1971). Rapid method for determination of arginase activity in tissue homogenates. Analytical Biochemistry, 39: 412-417.

Sengoku K, Tamate K, Yoshida T et al. (1998). Effects of low concentrations of nitric oxide on the zona pellucida binding ability of human spermatozoa. Fertility and Sterility, 69: 522-527.

Donnelly ET, Lewis SE, Thompson W et al. (1997). Sperm nitric oxide and motility: the effects of nitric oxide synthase stimulation and inhibition. Molecular Human Reproduction, 3: 755-762.

Aksoy H, Aksoy Y, Ozbey I et al. (2000). The relationship between varicocele and semen nitric oxide concentrations. Urological Research, 28: 357-359.

Herrero MB & Gagnon C (2001). Nitric oxide: a novel mediator of sperm function. Journal of Andrology, 22: 349-356.

Aitken RJ, Irvine DS & Wu FC (1991). Prospective analysis of sperm-oocyte fusion and reactive oxygen species generation as criteria for the diagnosis of infertility. American Journal of Obstetrics and Gynecology, 164: 542-551.

Wu G & Morris SM (1998). Arginine metabolism: nitric oxide and beyond. Biochemical Journal, 336: 1-7.

Chang C (1998). Arginase modulates nitric oxide production in activated macrophages. American Journal of Physiology, 274: H342-H348.

Hrabak A, Bajor T, Temesi A et al. (1996). The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase. FEBS Letters, 390: 203-206.

National Institutes of Health. National Institutes of Health Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.

Adman M, Effect of arginine on oligospermia. Fertil. Steril 1970 21:217-219

Holt LE, Albanesi AA, Observation of amino acids deficiencies in man. Trans. Assoc. Am. Physicians 1944 58:143-156

Aydin S, Inci O, Alagol B, The role of arginine indomethacin and kallikrein in the treatment of oligospermia. Int. Urol. Nephrol 1995 27:199-202

Scibona M, Meschini P, Capparelli S, Pecori C, Rossi P, Fabris GFM, Arginine and male infertility. Minerva Urol. Nefrol 1994 46:251-253

Radany EW, Atherton RW, Forrester IT, Arginine uptake by rabbit spermatozoa. Arch. Biochem. Biophys 1981 210:770-774

Patel AB, Srivastava S, Phadke RS, Govil G, Arginine activates glycolysis of goat epididymal spermatozoa: An NMR study. Biophys J 1998 75:1522-1528

Patel AB, Srivastava S, Phadke RS, Govil G, Arginine acts as a protective and reversal agent against glycolytic inhibitors in spermatozoa. Physiol Chem Phys Med NMR 1999 31:29-40

Mann T, Lutwak-Mann C, In: Male reproductive function and semen. Springer-Verlag Berlin Heidelberg New York 1981 213

Mann T, Lutwak-Mann C, In Aging gametes Ed.: R. J. Blandau Karger Basel 1975:122.

Govil G, Phadke RS, Srivastava S, In: Lipid soluble antioxidants: Biochemistry and clinical applications Ong ASH, Packer L (eds.), Birkhauser Verlag Basel/ Switzerland 1992 27-46

Srivastava S, Desai P, Coutinho E, Govil G, Protective effect of L-arginine against lipid peroxidation in goat epididymal spermatozoa. Physiol. Chem. Phys. & Med NMR 2000 32:127-135

Palmer RMJ, Ashton DS, Moncada S, Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988 33:664-668

Moncada S, Palmer RMJ, Higgs EA, Nitric oxide: physiology pathophysiology and pharmacology. Pharmacol. Rev 1992 43:109-142

White IG, Lipids and calcium uptake of sperm in relation to cold shock and preservation: a review. Reprod. Fertil. Dev 1993 5:639-658

Beuge JA, Aust SD, Methods. Enzymol 1978 52:302-310

Keller DW, Polakoski KL, L-arginine stimulation of human sperm motility in-vitro. Biol. Reprod 1975 13:154-160

Zini A, De Lamirande E, Gagnon C, Low levels of nitric oxide promote human sperm capacitation in vitro. J Androl 1995 16:424-431

Herrero MB, Viggiano JM, Perez Martinez S, de Gimeno MF, Evidence that nitric oxide synthase is involved in progesterone-induced acrosomal exocytosis in mouse spermatozoa. Reprod. Fertil. Dev 1997 9:433-439

Sengoku K, Tamate K, Yoshida T, Takaoka Y, Miyamoto T, Ishikawa M, Effects of low concentrations of nitric oxide on the zona pellucida binding ability of human spermatozoa. Fertil. Steril 1998 69:522-527

Revelli A, Costamagna C, Moffa F, Aldieri E, Ochetti S, Bosia A, Massobrio M, Lindblom B, Ghigo D, Signaling pathway of nitric oxide-induced acrosome reaction in human spermatozoa. Biol. Reprod 2001 64:1708-1712

Lipton SA, Neuronal protection and destruction by NO. Cell Death Differ 1999 6:943-951

Kisa U, Basar MM, Ferhat M, Yilmaz E, Basar H, Caglayan O, Batislam E, Testicular tissue nitric oxide and thiobarbituric acid reactive substance levels: evaluation with respect to the pathogenesis of varicocele. Urol Res 2004 32:196-199

Kausalya S, Nath J, . Interactive role of nitric oxide and superoxide anion in neutrophil-mediated endothelial cell injury Journal of Leukocyte Biology 1998 64:185-191

Sliwa L, Stochmal E, Effect of sodium nitroprusside on mouse sperm migration in vitro. Arch. Androl 2000 45:29-33

Sharma RK, Agarwal A, Artificial stimulation of cryopreserved human spermatozoa by sodium nitroprusside 2-chloroadenosine and 2-deoxyadenosine. Eur. Urol 1997 32:344-352

Hellstrom WJ, Bell M, Wang R, Sikka SC, Effect of sodium nitroprusside on sperm motility viability and lipid peroxidation. Fertil. Steril 1994 61:1117-1122

Viggiano JM, Herrero MB, Martinez SPDe, Gimeno MF, Analysis of the effect of nitric oxide synthase inhibition on mouse sperm employing a modified staining method for assessment of the acrosome reaction. J. Androl 1996 17:692-698

Knowles RG, Moncada S, Nitric oxide synthases in mammals. Biochem J 1994 298:249-58

Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990 101:746-52

Brown GC, Nitric oxide and mitochondrial respiration. Biochim. Biophys. Acta 1999 1411:351-369

Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–6.

Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–44.

Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

Rosen RC, Fisher WA, Eardley I et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004; 20: 607–17.

Minhas S, Eardley I. Diabetic impotence. In: Carson CK, Kirby R, Goldstein I, eds. Textbook of Erectile Dysfunction. Oxford: Isis Medical Media, 1999: 541–50.

Vinik A, Richardson D. Erectile dysfunction in diabetes. Diabetes Rev 1998; 6: 16–33.

Penson DF, Latini DM, Lubeck DP et al. Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003; 26: 1093–9.

Catania JA, Coates TJ, Stall R et al. Prevalence of AIDS-related risk factors and condom use in the United States. Science 1992; 258: 1101–6.

Dillman DA. Mail and Internet Surveys: the Tailored Design Method, 2nd edn. New York, NY: Wiley, 2000.

Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behaviour. Englewood Cliffs, NJ: Prentice Hall, 1980.

Davis CM, Yareber WL, Bauserman R, Schreer G, Davis SL. Handbook of Sexuality-related Measures. Thousand Oaks, CA: Sage, 1998.

Fisher WA, Fisher JD, Rye BJ. Understanding and promoting AIDS-preventive behavior: insights from the theory of reasoned action. Health Psychol 1995; 14: 255–64.

Fisher W, Boroditsky R, Morris B. The 2002 Canadian Contraception Study: Part 1. J Obstet Gynaecol Can 2004; 26: 580–90.

Fisher WA, Rosen RC, Eardley I et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) Study Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 2004; 1: 150–60.

Giuliano FA, Leriche A, Jaudinot EO et al. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004; 64: 1196–201.

Roth A, Kalter-Leibovici O, Kerbis Y et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. Clin Cardiol 2003; 26: 25–30.

Roumeguere T, Wespes E, Carpentier Y et al. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003; 44: 55–9.

Rosen RC, Wing R, Schneider S et al. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am 2005; 32: 403–17.

Sun P, Cameron A, Seftel A et al. Erectile dysfunction: an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 2006; 176: 1081–5.

Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2002; 2: 501–9.

Sussman DO. Pharmacokinetics, pharmacodynamics, and efficacy of phosphodiesterase type 5 inhibitors. J Am Osteopath Assoc 2004; 104 (3 Suppl. 4): S11–5.

Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res 2003; 15: 63–71.

Chew KK, Earle CM, Stuckey BG et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000; 12: 41–5.

Kitai E, Vinker S, Kijner F et al. Erectile dysfunction – the effect of sending a questionnaire to patients on consultations with their family doctor. Fam Pract 2002; 19: 247–50.

Ansong KS, Lewis C, Jenkins P et al. Help-seeking decisions among men with impotence. Urology 1998; 52: 834–7.

Braun M, Wassmer G, Klotz T et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey´. Int J Impot Res 2000; 12: 305–11.

Martin-Morales A, Sanchez-Cruz JJ, Saenz Tejada de I et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiologia de la disfuncion erectil masculina study. J Urol 2001; 166: 569–74 (discussion 574–5).

Moreira ED Jr, Abdo CH, Torres EB et al. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001; 58: 583–8.

Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19: 387–91.